Journal article
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Vaccine, Vol.39(22), pp.3053-3066
02/23/2021
DOI: 10.1016/j.vaccine.2021.01.055
PMID: 33637387
Abstract
This is a Brighton Collaboration Case Definition of the term “Vaccine Associated Enhanced Disease” to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission.
Details
- Title: Subtitle
- Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
- Creators
- Flor M Munoz - Departments of Pediatrics, Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USAJakob P Cramer - Coalition for Epidemic Preparedness Innovations, CEPI, London, UKCornelia L Dekker - Department of Pediatrics, Stanford University School of Medicine, CA, USAMatthew Z Dudley - Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USABarney S Graham - Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USAMarc Gurwith - Safety Platform for Emergency Vaccines, Los Altos Hills, CA, USABarbara Law - Safety Platform for Emergency Vaccines, Manta, EcuadorStanley Perlman - Department of Microbiology and Immunology, Department of Pediatrics, University of Iowa, USAFernando P Polack - Fundacion Infant, ArgentinaJonathan M Spergel - Division of Allergy and Immunology, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, PA, USAEva Van Braeckel - Department of Respiratory Medicine, Ghent University Hospital, and Department of Internal Medicine and Paediatrics, Ghent University, Ghent, BelgiumBrian J Ward - Research Institute of the McGill University Health Center, Montreal, Quebec, CanadaArnaud M Didierlaurent - Center of Vaccinology, University of Geneva, SwitzerlandPaul Henri Lambert - Center of Vaccinology, University of Geneva, Switzerland
- Resource Type
- Journal article
- Publication Details
- Vaccine, Vol.39(22), pp.3053-3066
- DOI
- 10.1016/j.vaccine.2021.01.055
- PMID
- 33637387
- NLM abbreviation
- Vaccine
- ISSN
- 0264-410X
- eISSN
- 1873-2518
- Publisher
- Elsevier Ltd
- Grant note
- DOI: 10.13039/100016302, name: Coalition for Epidemic Preparedness Innovations
- Language
- English
- Date published
- 02/23/2021
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Infectious Disease (Pediatrics)
- Record Identifier
- 9984070232702771
Metrics
30 Record Views